Projecting U.S. Antipsychotic Drug Demand 2025–2035: Market Insights
  The U.S. antipsychotic drugs market is set to experience steady and significant growth from 2025 through 2035, driven by rising prevalence of psychiatric disorders, expanding treatment options, and innovations in drug delivery. Market projections indicate that the U.S. market will reach $3.3 billion in 2025, expanding to approximately $5.9 billion by 2035, reflecting a compound annual...
0 Commentarios 0 Acciones 6 Views